Genmab A/S (GMAB)

Genmab Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2022	FY 2016	FY 2015
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2022	Dec 31, 2016	Dec 31, 2015
Revenue	22,844	21,526	14,505	3,706	2,269
Revenue Growth (YoY)	57.49%	48.40%	291.37%	63.31%	-
Cost of Revenue	1,297	985	-	-	-
Gross Profit	21,547	20,541	14,505	3,706	2,269
Selling, General & Admin	3,701	3,790	2,676	206.61	184.84
Research & Development	9,304	9,748	5,562	1,247	902.35
Other Operating Expenses	-	300	-	-	-176.22
Total Operating Expenses	13,005	13,838	8,238	1,453	910.98
Operating Income	8,517	6,703	6,267	2,253	1,535
Interest Income	3,216	4,438	3,189	174.93	112.99
Interest Expense	-1,794	-1,977	-2,511	-18.38	-58.62
Total Non-Operating Income (Expense)	1,421	2,461	678	156.55	54.38
Pretax Income	9,938	9,164	6,945	2,409	1,589
Provision for Income Taxes	1,477	1,320	1,493	-4.69	0.01
Net Income	8,462	7,844	5,452	2,518	1,601
Net Income to Common	8,462	7,844	5,452	2,518	1,601
Net Income Growth	55.20%	43.87%	116.49%	57.30%	-
Shares Outstanding (Basic)	652	642	654	579	562
Shares Outstanding (Diluted)	652	646	660	602	570
Shares Change (YoY)	-1.27%	-2.09%	9.72%	5.50%	-
EPS (Basic)	12.98	12.22	8.34	14.38	0.48
EPS (Diluted)	12.98	12.14	8.26	14.00	0.48
EPS Growth	57.20%	46.94%	-41.01%	2829.08%	-
Free Cash Flow	1,208	1,058	517.44	110.94	94.04
Free Cash Flow Growth	14.17%	104.50%	366.42%	17.96%	-
Free Cash Flow Per Share	-	1.64	0.78	0.18	0.16
Gross Margin	94.29%	95.42%	100.00%	100.00%	100.00%
Operating Margin	37.40%	31.14%	43.21%	60.78%	67.62%
Profit Margin	36.91%	36.44%	37.59%	67.95%	70.55%
FCF Margin	34.79%	35.23%	24.78%	21.09%	28.44%
EBITDA	1,364	992.84	954.13	319.73	223.62
EBITDA Margin	39.28%	33.06%	45.70%	60.78%	67.62%
EBIT	8,517	6,703	6,267	2,253	1,535
EBIT Margin	37.40%	31.14%	43.21%	60.78%	67.62%
Effective Tax Rate	15.14%	14.40%	21.50%	-0.19%	0.00%

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q